Clarithromycin reduces prednisolone requirements for treatment of intractable Takayasu arteritis.
Yamaguchi
K
K
Yamamoto
Y
Y
Murashima
A
A
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002339:Carotid Arteries / Q000473:pathology; D017291:Clarithromycin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008279:Magnetic Resonance Imaging; D011239:Prednisolone / Q000627:therapeutic use*; D013348:Subclavian Artery / Q000473:pathology; D013625:Takayasu Arteritis / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D011239:Prednisolone; D017291:Clarithromycin